[Acral scleroderma presenting simultaneously with small-cell bronchial carcinoma: a paraneoplastic disease?]
Jessica Merkl1, Holger Poppert, Rüdiger Hein
1Klinik und Poliklinik für Dermatologie und Allergologie am Biederstein der Technischen Universität München.
Summary
Systemic scleroderma and cancer link remains debated. In a rare case, scleroderma appeared after lung cancer, suggesting a paraneoplastic syndrome possibly driven by growth factors.
Area of Science:
- Rheumatology and Oncology
- Immunodermatology
- Pathophysiology of Fibrotic Diseases
Background:
- The relationship between systemic scleroderma and malignant neoplasms is controversial.
- Malignant tumors may trigger dermatomyositis, while scleroderma's fibrosis is suspected to cause tumors.
- Understanding this link is crucial for diagnosing and managing complex cases.
Observation:
- A 68-year-old woman with acral scleroderma presented with metastatic bronchial carcinoma.
- No prior pulmonary fibrosis was noted.
- Scleroderma developed rapidly after the cancer diagnosis but before treatment.
Findings:
- The case suggests scleroderma may be a paraneoplastic syndrome in this instance.
- Growth factors and cytokines are implicated in both neoplastic transformation and fibroblast profibrotic changes.
- The temporal sequence excludes pulmonary fibrosis and treatment side effects as triggers.
Implications:
- This case highlights the potential for scleroderma to manifest as a paraneoplastic phenomenon.
- Further research into growth factors and cytokines could elucidate the mechanisms linking cancer and fibrosis.
- Recognizing scleroderma as a paraneoplastic syndrome may improve early cancer detection in specific patient populations.